Objectives
The aim of the study was to estimate the rate of adverse reactions to live BCG Moreau vaccine, manufactured by Biomed in Poland, in severe combined immunodeficiency (SCID) patients.Material
The profiles of 52 SCID patients vaccinated at birth with BCG, hospitalized in Chil...
